Literature DB >> 4564890

Pyelonephritis. XIV. Effect of immunization on experimental Escherichia coli pyelonephritis.

J Z Montgomerie, G M Kalmanson, E G Hubert, L B Guze.   

Abstract

Mice immunized subcutaneously with heat-killed Escherichia coli were protected from pyelonephritis produced by the intravenous route, but there was little or no protection from ascending infection. No significant protection from ascending or hematogenous pyelonephritis was demonstrated when immunization was accomplished by injecting heat-killed E. coli into the bladder. Heat-killed E. coli injected either subcutaneously or into the bladder protected mice from early endotoxic death after intravenous or bladder challenge.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4564890      PMCID: PMC422536          DOI: 10.1128/iai.6.3.330-334.1972

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  Bacterial pyrogens.

Authors:  I L BENNETT; L E CLUFF
Journal:  Pharmacol Rev       Date:  1957-12       Impact factor: 25.468

2.  Secretory gamma-A in normal urine.

Authors:  J Bienenstock; T B Tomasi
Journal:  J Clin Invest       Date:  1968-05       Impact factor: 14.808

3.  Immunoglobulin synthesis in lower urinary tract infection.

Authors:  W L Hand; J W Smith; T E Miller; J A Barnett; J P Sanford
Journal:  J Lab Clin Med       Date:  1970-01

4.  Serum antibody effect on induced bladder infection.

Authors:  D T Uehling; M Constant
Journal:  Invest Urol       Date:  1970-07

5.  Effect of physical state and route of inoculation of diphtheria toxoid on the formation of nasal secretory and serum antibodies in man.

Authors:  W T Butler; R D Rossen; R D Wenden
Journal:  J Immunol       Date:  1970-06       Impact factor: 5.422

6.  Local immune response in experimental pyelonephritis.

Authors:  J D Lehmann; J W Smith; T E Miller; J A Barnett; J P Sanford
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

7.  Antibacterial mechanisms of the urinary bladder.

Authors:  C W Norden; G M Green; E H Kass
Journal:  J Clin Invest       Date:  1968-12       Impact factor: 14.808

8.  Prevention of experimental hematogenous and retrograde pyelonephritis by antibodies against enterobacterial common antigen.

Authors:  G Domingue; A Salhi; C Rountree; W Little
Journal:  Infect Immun       Date:  1970-08       Impact factor: 3.441

9.  Experimental pyelonephritis. XIV. Pyelonephritis in normal mice produced by inoculation of E. coli into the bladder lumen during water diuresis.

Authors:  W F Keane; L R Freedman
Journal:  Yale J Biol Med       Date:  1967-12

10.  THE ROLE OF IMMUNITY IN THE PATHOGENESIS OF EXPERIMENTAL RETROGRADE PYELONEPHRITIS.

Authors:  B W HUNTER; L L AKINS; J P SANFORD
Journal:  J Exp Med       Date:  1964-01-01       Impact factor: 14.307

View more
  2 in total

1.  P-fimbriae vaccines. II. Cross reactive protection against pyelonephritis.

Authors:  J A Roberts; M B Kaack; G Baskin; T K Korhonen; S B Svenson; J Winberg
Journal:  Pediatr Nephrol       Date:  1989-10       Impact factor: 3.714

2.  Antigen presentation as a factor in the protective immune response to renal infection.

Authors:  T E Miller; S Burnham
Journal:  Clin Exp Immunol       Date:  1975-11       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.